Top

Journal of Cancer Research and Clinical Oncology

Published in:

01-09-2012 | Original Paper

Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7,12 dimethylbenz(α)anthracene and decreases cell proliferation: comparison with tamoxifen

Authors: Ahmed Mansour, Ayman Daba, Nahed Baddour, Muhammed El-Saadani, Eiman Aleem

Published in: Journal of Cancer Research and Clinical Oncology | Issue 9/2012

Abstract

Background

Breast cancer is one of the leading causes of cancer mortality among women. Some anticancer compounds have been isolated from mushrooms. The aim of the present work was to study the anticancer effects of schizophyllan (SCH), a β-d-glucan extracted from the mushroom Schizophyllum commune alone or in combination with tamoxifen (TAM) on 7, 12 Dimethylbenz(α)anthracene (DMBA)-induced carcinomas in mice.

Methods

We isolated SCH from S. commune. Female mice received DMBA, SCH, DMBA+SCH, DMBA+TAM or DMBA+TAM+SCH or vehicles. We studied mice survival, tumour incidence, histopathology, oestrogen receptor (ER) expression, cell proliferation by immunohistochemical detection of proliferating cell nuclear antigen (PCNA), apoptosis by TUNEL assay, as well as caspase-3 expression.

Results

DMBA treatment resulted in mammary and hepatocellular carcinomas (HCC). Both SCH and TAM reduced the incidence of DMBA-induced mammary tumours by 85 and 75 %, respectively, and equally decreased the PCNA labelling index relative to DMBA. TAM treatment increased the incidence of- and PCNA index in HCCs relative to DMBA, while SCH suppressed these effects. TAM was more effective than SCH in the induction of apoptosis in both mammary and hepatic carcinomas. Caspase-3 levels correlated with the apoptotic index in most experimental groups.

Conclusions

Only one dose of SCH had similar therapeutic effects against DMBA-induced mammary carcinomas as 4 weeks of TAM treatment. This coupled with the ability of SCH to suppress hepatic lesions associated with TAM treatment provides the rationale for further investigating the combined therapeutic effects of TAM+SCH in preclinical models of ER-positive breast cancer, as well as in liver cancer.

Available only for authorised users

Abraham RJ, Loftus P (1978) Proton and carbon-13 NMR spectroscopy: an integrated approach. Heyden, London

Akhondi-Meybodi M, Mortazavy-Zadah MR, Hashemian Z, Moaiedi M (2011) Incidence and risk factors for non-alcoholic steatohepatitis in females treated with tamoxifen for breast cancer. Arab J Gastroenterol 12(1):34–36PubMedCrossRef

Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol Off J US Can Acad Pathol Inc 11(2):155–168

Axelrod R, Axelrod DE, Pienta KJ (2006) Evolution of cooperation among tumor cells. Proc Natl Acad Sci USA 103(36):13474–13479PubMedCrossRef

Bernstein L, Deapen D, Cerhan JR, Schwartz SM, Liff J, McGann-Maloney E, Perlman JA, Ford L (1999) Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst 91(19):1654–1662PubMedCrossRef

Bohn JA, BeMiller JN (1995) (1– >3)-beta-d-glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydr Polym 28(1):3–14CrossRef

Borchers AT, Stern JS, Hackman RM, Keen CL, Gershwin ME (1999) Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med 221(4):281–293PubMedCrossRef

Borchers AT, Keen CL, Gershwin ME (2004) Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood) 229(5):393–406

Burchiel SW, Davis DA, Ray SD, Barton SL (1993) DMBA induces programmed cell death (apoptosis) in the A20.1 murine B cell lymphoma. Fundam Appl Toxicol Off J Soc Toxicol 21(1):120–124CrossRef

Chihara G, Maeda Y, Hamuro J, Sasaki T, Fukuoka F (1969) Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) sing. Nature 222(5194):687–688PubMedCrossRef

Chihara G, Hamuro J, Maeda Y, Arai Y, Fukuoka F (1970) Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing. (an edible mushroom). Cancer Res 30(11):2776–2781PubMed

de Sousa JA, Facina G, da Silva BB, Gebrim LH (2006) Effects of low-dose tamoxifen on breast cancer biomarkers Ki-67, estrogen and progesterone receptors. Int Semin Surg Oncol ISSO 3:29CrossRef

Di Cosimo S, Baselga J (2008) Targeted therapies in breast cancer: where are we now? Eur J Cancer 44(18):2781–2790PubMedCrossRef

Dragan YP, Fahey S, Nuwaysir E, Sattler C, Babcock K, Vaughan J, McCague R, Jordan VC, Pitot HC (1996) The effect of tamoxifen and two of its non-isomerizable fixed-ring analogs on multistage rat hepatocarcinogenesis. Carcinogenesis 17(3):585–594PubMedCrossRef

Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18):1371–1388PubMedCrossRef

Frankfurt OS, Sugarbaker EV, Robb JA, Villa L (1995) Synergistic induction of apoptosis in breast cancer cells by tamoxifen and calmodulin inhibitors. Cancer Lett 97(2):149–154PubMedCrossRef

Fu X, Latendresse JR, Muskhelishvili L, Blaydes BS, Delclos KB (2005) Dietary modulation of 7,12-dimethylbenz[a]anthracene (DMBA)-induced adrenal toxicity in female Sprague-Dawley rats. Food Chem Toxicol Int J Pub Br Ind Biol Res Assoc 43(5):765–774

Fu H, Guo WY, Yin H, Wang ZX, Li RD (2011) Inhibition of Lentinus edodes polysaccharides against liver tumour growth. Int J Phys Sci 6(1):116–120

Fujii T, Maeda H, Suzuki F, Ishida N (1978) Isolation and characterization of a new antitumor polysaccharide, KS-2, extracted from culture mycelia of Lentinus edodes. J Antibiot 31(11):1079–1090PubMedCrossRef

Fujimoto S, Furue H, Kimura T, Kondo T, Orita K, Taguchi T, Yoshida K, Ogawa N (1991) Clinical outcome of postoperative adjuvant immunochemotherapy with sizofiran for patients with resectable gastric cancer: a randomised controlled study. Eur J Cancer 27(9):1114–1118PubMedCrossRef

Garrity MM, Burgart LJ, Riehle DL, Hill EM, Sebo TJ, Witzig T (2003) Identifying and quantifying apoptosis: navigating technical pitfalls. Mod Pathol Off J U S Can Acad Pathol Inc 16(4):389–394

Greaves P, Goonetilleke R, Nunn G, Topham J, Orton T (1993) Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats. Cancer Res 53(17):3919–3924PubMed

Hard GC, Williams GM, Iatropoulos MJ (1993) Tamoxifen and liver cancer. Lancet 342(8868):444–445PubMedCrossRef

Herold C, Ganslmayer M, Ocker M, Hermann M, Hahn EG, Schuppan D (2002) Combined in vitro anti-tumoral action of tamoxifen and retinoic acid derivatives in hepatoma cells. Int J Oncol 20(1):89–96PubMed

Inoue M, Tanaka Y, Sugita N, Yamasaki M, Yamanaka T, Minagawa J, Nakamuro K, Tani T, Okudaira Y, Karita T et al (1993) Improvement of long-term prognosis in patients with ovarian cancers by adjuvant sizofiran immunotherapy: a prospective randomized controlled study. Biotherapy 6(1):13–18PubMedCrossRef

Ishizuka Y, Tsukada H, Gejyo F (2004) Interference of (1– >3)-beta-d-glucan administration in the measurement of plasma (1– >3)-beta-d-glucan. Intern Med 43(2):97–101PubMedCrossRef

Jones LP, Li M, Halama ED, Ma Y, Lubet R, Grubbs CJ, Deng CX, Rosen EM, Furth PA (2005) Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer. Oncogene 24(22):3554–3562PubMedCrossRef

Killackey MA, Hakes TB, Pierce VK (1985) Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens. Cancer Treat Rep 69(2):237–238PubMed

Kimura Y, Tojima H, Fukase S, Takeda K (1994) Clinical evaluation of sizofilan as assistant immunotherapy in treatment of head and neck cancer. Acta Otolaryngol Suppl 511:192–195PubMedCrossRef

Kodama N, Komuta K, Nanba H (2002) Can maitake MD-fraction aid cancer patients? Altern Med Rev 7(3):236–239PubMed

Kodama N, Komuta K, Nanba H (2003) Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients. J Med Food 6(4):371–377PubMedCrossRef

Komatsu N, Okubo S, Kikumoto S, Kimura K, Saito G (1969) Host-mediated antitumor action of schizophyllan, a glucan produced by Schizophyllum commune. Gann 60(2):137–144PubMed

Lee SH, Hwang HS, Yun JW (2009) Antitumor activity of water extract of a mushroom, Inonotus obliquus, against HT-29 human colon cancer cells. Phytother Res 23(12):1784–1789PubMedCrossRef

Lehne G, Haneberg B, Gaustad P, Johansen PW, Preus H, Abrahamsen TG (2006) Oral administration of a new soluble branched beta-1,3-d-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers. Clin Exp Immunol 143(1):65–69PubMedCrossRef

Lindequist U, Niedermeyer TH, Julich WD (2005) The pharmacological potential of mushrooms. Evid Based Complement Alternat Med 2(3):285–299PubMedCrossRef

Mandlekar S, Yu R, Tan TH, Kong AN (2000) Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Res 60(21):5995–6000PubMed

Martin KR, Brophy SK (2010) Commonly consumed and specialty dietary mushrooms reduce cellular proliferation in MCF-7 human breast cancer cells. Exp Biol Med (Maywood) 235(11):1306–1314CrossRef

Miyazaki K, Mizutani H, Katabuchi H, Fukuma K, Fujisaki S, Okamura H (1995) Activated (HLA-DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell-mediated immunity and survival. Gynecol Oncol 56(3):412–420PubMedCrossRef

Nakano T, Oka K, Hanba K, Morita S (1996) Intratumoral administration of sizofiran activates Langerhans cell and T-cell infiltration in cervical cancer. Clin Immunol Immunopathol 79(1):79–86PubMedCrossRef

Nemoto Y, Saibara T, Ogawa Y, Zhang T, Xu N, Ono M, Akisawa N, Iwasaki S, Maeda T, Onishi S (2002) Tamoxifen-induced nonalcoholic steatohepatitis in breast cancer patients treated with adjuvant tamoxifen. Intern Med 41(5):345–350PubMedCrossRef

Noda K, Takeuchi S, Yajima A, Akiya K, Kasamatsu T, Tomoda Y, Ozawa M, Sekiba K, Sugimori H, Hashimoto S et al (1992) Clinical effect of sizofiran combined with irradiation in cervical cancer patients: a randomized controlled study. Cooperative study group on SPG for gynecological cancer. Jpn J Clin Oncol 22(1):17–25PubMed

Obrero M, Yu DV, Shapiro DJ (2002) Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death. J Biol Chem 277(47):45695–45703PubMedCrossRef

Okamura K, Suzuki M, Chihara T, Fujiwara A, Fukuda T, Goto S, Ichinohe K, Jimi S, Kasamatsu T, Kawai N et al (1989) Clinical evaluation of sizofiran combined with irradiation in patients with cervical cancer. A randomized controlled study; a five-year survival rate. Biotherapy 1(2):103–107PubMedCrossRef

Ooi VE, Liu F (2000) Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 7(7):715–729PubMedCrossRef

Osborne CK, Boldt DH, Clark GM, Trent JM (1983) Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 43(8):3583–3585PubMed

Pogribny IP, Bagnyukova TV, Tryndyak VP, Muskhelishvili L, Rodriguez-Juarez R, Kovalchuk O, Han T, Fuscoe JC, Ross SA, Beland FA (2007) Gene expression profiling reveals underlying molecular mechanisms of the early stages of tamoxifen-induced rat hepatocarcinogenesis. Toxicol Appl Pharmacol 225(1):61–69PubMedCrossRef

Rau U, Gura E, Olszewski E, Wagner F (1992) enhanced glucan formation of filamentous fungi by effective mixing, oxygen limitation and fed-batch processing. J Ind Microbiol 9(1):19–25CrossRef

Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ (1990) Comparative study of human and rat mammary tumorigenesis. Lab Invest 62(3):244–278PubMed

Shin A, Kim J, Lim SY, Kim G, Sung MK, Lee ES, Ro J (2010) Dietary mushroom intake and the risk of breast cancer based on hormone receptor status. Nutr Cancer 62(4):476–483PubMedCrossRef

Sullivan R, Smith JE, Rowan NJ (2006) Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine. Perspect Biol Med 49(2):159–170PubMedCrossRef

Tanji S, Akima K, Horiba M, Amemiya K, Aimoto T (1990) Studies on metabolism and disposition of sizofiran (SPG), an anti-tumor polysaccharide. III. Degradation and excretion of SPG in rats. Yakugaku Zasshi 110(11):869–875PubMed

Tokuyasu H, Takeda K, Kawasaki Y, Sakaguchi Y, Isowa N, Shimizu E, Ueda Y (2010) High plasma concentration of beta-d-glucan after administration of sizofiran for cervical cancer. Int J Gen Med 3:273–277PubMed

Tryndyak VP, Kovalchuk O, Muskhelishvili L, Montgomery B, Rodriguez-Juarez R, Melnyk S, Ross SA, Beland FA, Pogribny IP (2007) Epigenetic reprogramming of liver cells in tamoxifen-induced rat hepatocarcinogenesis. Mol Carcinog 46(3):187–197PubMedCrossRef

Tsai-Turton M, Nakamura BN, Luderer U (2007) Induction of apoptosis by 9,10-dimethyl-1,2-benzanthracene in cultured preovulatory rat follicles is preceded by a rise in reactive oxygen species and is prevented by glutathione. Biol Reprod 77(3):442–451PubMedCrossRef

Williams GM, Iatropoulos MJ, Karlsson S (1997) Initiating activity of the anti-estrogen tamoxifen, but not toremifene in rat liver. Carcinogenesis 18(11):2247–2253PubMedCrossRef

Wu D, Pae M, Ren Z, Guo Z, Smith D, Meydani SN (2007) Dietary supplementation with white button mushroom enhances natural killer cell activity in C57BL/6 mice. J Nutr 137(6):1472–1477PubMed

Youn MJ, Kim JK, Park SY, Kim Y, Park C, Kim ES, Park KI, So HS, Park R (2009) Potential anticancer properties of the water extract of Inonotus [corrected] obliquus by induction of apoptosis in melanoma B16-F10 cells. J Ethnopharmacol 121(2):221–228PubMedCrossRef

Yu L, Fernig DG, Smith JA, Milton JD, Rhodes JM (1993) Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin. Cancer Res 53(19):4627–4632PubMed

Zhang GJ, Kimijima I, Onda M, Kanno M, Sato H, Watanabe T, Tsuchiya A, Abe R, Takenoshita S (1999) Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels. Clin Cancer Res Off J Am Assoc Cancer Res 5(10):2971–2977

Zhang M, Huang J, Xie X, Holman CD (2009) Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. Int J Cancer 124(6):1404–1408PubMedCrossRef

Title: Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7,12 dimethylbenz(α)anthracene and decreases cell proliferation: comparison with tamoxifen
Authors: Ahmed Mansour
Ayman Daba
Nahed Baddour
Muhammed El-Saadani
Eiman Aleem
Publication date: 01-09-2012
Publisher: Springer-Verlag
Published in: Journal of Cancer Research and Clinical Oncology / Issue 9/2012
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-012-1224-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2012

Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesion: a systematic review

External validity of the Tokuhashi score in patients with vertebral metastasis

Clinical outcomes of single or oligo-fractionated stereotactic radiotherapy for head and neck tumors using micromultileaf collimator-based dynamic conformal arcs

Anti-EGFR (cetuximab) combined with irinotecan for treatment of elderly patients with metastatic colorectal cancer (mCRC)

Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy

Triptolide triggers the apoptosis of pancreatic cancer cells via the downregulation of Decoy receptor 3 expression

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials